| 30.06.2022 11:22 | AVCT | Avacta's partner LG Chem renews licence to develop Affimer platform | Alliance |
| 30.06.2022 07:00 | AVCT | LG Chem renews license triggers payment to Avacta | RNS |
| 29.06.2022 11:38 | DELT, SAE, AVCT | AIM WINNERS & LOSERS: Deltic rises on Shell deal; Windar down on delay | Alliance |
| 29.06.2022 10:21 | AVCT | Avacta shares up as cancer drug AVA6000 advances to third dose cohort | Alliance |
| 29.06.2022 09:05 | AVCT | Second Price Monitoring Extn | RNS |
| 29.06.2022 09:00 | AVCT | Price Monitoring Extension | RNS |
| 29.06.2022 07:00 | AVCT | Second dose escalation in phase 1 trial of AVA6000 | RNS |
| 23.06.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 23.06.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
| 23.06.2022 16:27 | AVCT | Result of Annual General Meeting | RNS |
| 16.06.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 16.06.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
| 16.06.2022 16:03 | ZNWD, TND, RBGP | UK shareholder meetings calendar - next 7 days | Alliance |
| 31.05.2022 07:00 | AVCT | Posting of Annual Report and Notice of AGM | RNS |
| 16.05.2022 14:04 | AVCT | IN BRIEF: Avacta joint venture expands partnership with GenScript | Alliance |
| 16.05.2022 12:00 | AVCT | AffyXell expands partnership with GenScript ProBio | RNS |
| 11.05.2022 07:00 | AVCT | London Therapeutics headquarters established | Reach |
| 06.05.2022 07:00 | AVCT | Block Listing Application to AIM (update) | RNS |
| 28.04.2022 13:53 | AVCT | Block Listing Application to AIM | RNS |
| 14.04.2022 17:01 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 14.04.2022 11:29 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 13.04.2022 17:33 | AVCT | Avacta increases shareholding in drug developer AffyXell to 22% | Alliance |
| 13.04.2022 07:00 | AVCT | AffyXell milestone and increased equity stake | RNS |
| 12.04.2022 07:00 | AVCT | Poster presented at the AACR available to download | RNS |
| 11.04.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 11.04.2022 16:35 | AVCT | Price Monitoring Extension | RNS |
| 11.04.2022 14:05 | AVCT | Second Price Monitoring Extn | RNS |
| 11.04.2022 14:00 | AVCT | Price Monitoring Extension | RNS |
| 08.04.2022 13:57 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 08.04.2022 11:28 | JET2, AVCT, JNEO | AIM WINNERS & LOSERS: Sensyne Health drops amid AIM delisting warning | Alliance |
| 08.04.2022 10:37 | AVCT | Avacta joint venture to collaborate with Chinese biological company | Alliance |
| 08.04.2022 07:00 | AVCT | AffyXell partners with Biocytogen and KNTSC | RNS |
| 07.04.2022 16:31 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 06.04.2022 10:23 | AVCT | IN BRIEF: Avacta widens annual loss on research, manufacturing costs | Alliance |
| 06.04.2022 07:00 | AVCT | Preliminary Results | RNS |
| 30.03.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 30.03.2022 16:35 | AVCT | Price Monitoring Extension | RNS |
| 30.03.2022 07:00 | AVCT | Notice of Results and Investor Presentation | RNS |
| 29.03.2022 07:00 | AVCT | AVA6000 data poster presentation at AACR | RNS |
| 21.03.2022 07:00 | AVCT | Directorate Change | RNS |
| 16.03.2022 11:38 | AVCT | Avacta sells veterinary division to Vimian for up to GBP2.3 million | Alliance |
| 16.03.2022 07:00 | AVCT | Vimian acquires Avacta’s Animal Health Division | RNS |
| 14.02.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 14.02.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
| 07.02.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
| 03.02.2022 17:26 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 03.02.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 03.02.2022 16:35 | AVCT | Price Monitoring Extension | RNS |
| 03.02.2022 11:10 | AVCT | Avacta shares up 12% after chemotherapy drug advances to next stage | Alliance |
| 03.02.2022 07:00 | AVCT | Dose escalation in the phase I trial of AVA6000 | RNS |
| 31.01.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 31.01.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
| 18.01.2022 07:00 | AVCT | Second pre|CISION Pro-drug Candidate Selected | RNS |
| 12.01.2022 14:05 | AVCT | Second Price Monitoring Extn | RNS |
| 12.01.2022 14:00 | AVCT | Price Monitoring Extension | RNS |
| 10.01.2022 07:00 | AVCT | Update on AffiDX and detection of Omicron variant | RNS |
| 04.01.2022 11:06 | AVCT | Second Price Monitoring Extn | RNS |
| 04.01.2022 11:01 | AVCT | Price Monitoring Extension | RNS |
| 22.12.2021 16:26 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 22.12.2021 11:05 | AVCT | Second Price Monitoring Extn | RNS |
| 22.12.2021 11:00 | AVCT | Price Monitoring Extension | RNS |
| 22.12.2021 07:00 | AVCT | AffiDX Receives CE Mark for Consumer Self-Testing | RNS |
| 16.12.2021 07:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 15.12.2021 07:00 | AVCT | AffiDx® lateral flow test detects Omicron variant | RNS |
| 15.12.2021 07:00 | AVCT | Change of auditor | RNS |
| 29.11.2021 07:00 | AVCT | FDA Approval of IND Application for AVA6000 | RNS |
| 18.11.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 18.11.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 02.11.2021 07:00 | AVCT | Update on UK Availability of AffiDX Test | RNS |
| 14.10.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 14.10.2021 12:36 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 30.09.2021 07:00 | AVCT | Interim Results for the Period Ended 30 June 2021 | RNS |
| 29.09.2021 07:00 | AVCT | Development Milestone in LG Chem Partnership | RNS |
| 22.09.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 22.09.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
